drugset
drugset / Trial / NCT04546984

Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

NCT04546984 ↗

Phase 1 Completed 66 enrolled Sunshine Lake Pharma Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The Safety, Tolerability, Pharmacokinetic, Pharmacodynamics and Food Effect Study of HEC96719 in Healthy Subjects

Timeline

Start
2020-09-14
Primary completion
2020-12-29
Completion
2020-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject HEC96719 Unknown — —

Indications

metabolic dysfunction-associated steatohepatitis